Anna Kruschinski

The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization

Julia Hoellenriegel, Dirk Zboralski, Christian Maasch et al. · Blood · 2013 · 236 citations · Full text

Medicine, Cell Biology, Oncology +8

Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas

Anna Kruschinski, Andreas Moosmann, Isabel Poschke et al. · Proceedings of the National Academy of Sciences · 2008 · 195 citations · Full text

Life Sciences, Immunology, Oncology +17

SDF-1 Inhibition Targets the Bone Marrow Niche for Cancer Therapy

Aldo M. Roccaro, Antonio Sacco, Werner G. Purschke et al. · Cell Reports · 2014 · 139 citations · Full text

Medicine, Cancer Biology, Oncology +17

Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats

Shie-Chau Liu, Reem Alomran, Sophia B. Chernikova et al. · Neuro-Oncology · 2013 · 93 citations · Full text

Medicine, Oncology, Pharmacology +13

Hematopoietic Stem and Progenitor Cell Mobilization in Mice and Humans by a First-in-Class Mirror-Image Oligonucleotide Inhibitor of CXCL12

Axel Vater, Jörg Sahlmann, Nicolaus Kröger et al. · Clinical Pharmacology & Therapeutics · 2013 · 88 citations · Full text

Veterinary Medicine, Hematology, Pharmacology +17